Literature DB >> 3130077

Generalized papular pruritic eruption in African patients with human immunodeficiency virus infection.

R Colebunders1, J M Mann, H Francis, K Bila, L Izaley, N Kakonde, A F Hood, T C Quinn, P Gigase, E Van Marck.   

Abstract

Of 284 patients hospitalized with HIV infection, 52 (18%) presented with a generalized pruritic papular eruption. No significant association between this eruption and other HIV manifestations or any opportunistic infection was found. Fifty-three of 61 (87%) consecutive African patients referred for a generalized papular pruritic eruption of unknown etiology of at least 1 month's duration were HIV seropositive, including 15 (65%) of 23 in good general condition. Thirty-seven (95%) of 38 patients with this eruption and severe weight loss (greater than 10% of normal body weight) were seropositive. The initial skin lesions were small, firm, intensely pruritic papules which released a small drop of clear fluid when scratched. Scratched papules became later hyperpigmented macules. Lesions were symmetrically distributed over the body and were most frequently found on the extensor surfaces of the arm, the dorsal surface of the hands, the inferior part of the legs, the ankles and the dorsum of the feet. Histologic examination showed a non-specific inflammatory reaction. Thirty-three (51%) patients reported that the skin eruption was their initial disease manifestation. In African patients, the presence of an unexplained generalized pruritic papular eruption is highly indicative of HIV infection.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Anatomy; Antibodies--analysis; Biology; Data Analysis; Dermatitis; Dermatological Effects; Developing Countries; Diseases; Examinations And Diagnoses; French Speaking Africa; Histology; Hiv Infections--indications; Immunity; Immunologic Factors; Incidence; Laboratory Examinations And Diagnoses; Measurement; Middle Africa; Physiology; Pruritus; Research Methodology; Viral Diseases; Zaire

Mesh:

Year:  1987        PMID: 3130077

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  Factors associated with pruritic papular eruption of human immunodeficiency virus infection in the antiretroviral therapy era.

Authors:  S L Chua; E H Amerson; K S Leslie; T H McCalmont; P E Leboit; J N Martin; D Bangsberg; T A Maurer
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

2.  Pruritic papular eruptions as presenting illness of HIV.

Authors:  Smriti Naswa; Ravi Khambhati; Y S Marfatia
Journal:  Indian J Sex Transm Dis AIDS       Date:  2011-07

3.  Etiology and risk factors associated with a pruritic papular eruption in people living with HIV in India.

Authors:  Terry T Farsani; Sachin Kore; Patrick Nadol; Mandalaparthy Ramam; Sara J Thierman; Kieron Leslie; Chockalingam Chandrasekar; Rajasekaran Sikhamani; Gurusamy Manoharan; Asha Kubba; Toby A Maurer
Journal:  J Int AIDS Soc       Date:  2013-09-03       Impact factor: 5.396

4.  Thalidomide-A novel therapeutic approach for pruritic papular eruption of HIV.

Authors:  Aaron Giles Wernham; Bindu Vydianath; Ser Ling Chua
Journal:  JAAD Case Rep       Date:  2015-05-02

5.  Immune reconstitution inflammatory syndrome associated with dermatophytoses in two HIV-1 positive patients in rural Tanzania: a case report.

Authors:  Herry Mapesi; Adrià Ramírez; Marcel Tanner; Christoph Hatz; Emilio Letang
Journal:  BMC Infect Dis       Date:  2016-09-20       Impact factor: 3.090

6.  Prevalence of pruritic papular eruption among HIV patients: A cross-sectional study.

Authors:  Shoubin Mohammed; Seethalakshmi Ganga Vellaisamy; Kannan Gopalan; Lekha Sukumaran; A S Valan
Journal:  Indian J Sex Transm Dis AIDS       Date:  2019 Jul-Dec

7.  Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis.

Authors:  Andrew J Prendergast; Mutsa Bwakura-Dangarembizi; Peter Mugyenyi; Joseph Lutaakome; Adeodata Kekitiinwa; Margaret J Thomason; Diana M Gibb; A Sarah Walker
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.